Clinical Trials Browser

Active not recruiting × Glioblastoma × poly ICLC × Clear all

NCT03223103 2025-09-10

Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma

Phase 1 Active not recruiting

Brain Neoplasms, Glioblastoma, Neoplasms

NCT04201873 2025-08-22

Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

Phase 1 Active not recruiting

Glioblastoma